Remarkable progress has been made in establishing the field of genomic medicine during the past decade. A host of therapeutic and diagnostic tools—such as the use of molecular simulations to identify new drug pathways1 and gene expression profiles to predict the course of breast cancer2—are moving from the laboratory to the marketplace. Amid the speculation about possible applications and effects of this new medical discipline, 2 major projections have emerged. One predicts that genomic medicine will disrupt many aspects of health care, making current models of its delivery obsolete. Recent reports by the UK National Health Service3 and the US National Human Genome Research Institute4,5 reflect this view. The other is less radical, projecting an initial enhancement of current uses of DNA and genetic information, followed by a gradual diffusion of new genomic medical information and technologies throughout the health care system.6- 8
Individuals receiving certificates during years when tests were offered by the American Board of Medical Genetics (ABMG).14
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 11
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.